Aclarion, Inc. (ACONW) cash flow statement

ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 8/30

$0.02+0.00 (0.00%)

Close on Oct 30, 2026Market cap $5.62MP/E –Yield –

Aclarion, Inc. cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31
Depreciation & Amortization	0.06	0.06	0.06	0.06	0.05	0.06	0.05	0.05	0.05	0.05	0.04	0.04	0.04	0.04	0.04	0.03	0.05	0.05	0.05	0.04
Stock-Based Compensation	0.10	0.00	0.00	0.02	0.03	0.06	0.06	0.07	0.07	0.09	0.10	0.14	0.14	0.08	0.14	0.70	0.08	0.08	0.00	0.00
Change in Accounts Receivable	0.01	-0.01	0.00	-0.01	0.00	0.00	0.01	0.00	0.00	0.00	0.01	-0.01	0.00	0.00	0.01	-0.02	0.00	0.02	0.00	-0.01
Change in Accounts Payable	0.13	0.24	0.02	0.05	-0.25	-0.02	0.29	0.10	0.10	-0.64	0.01	0.15	-0.02	0.08	-0.26	-0.47	0.04	0.08	-0.09	0.17
Operating Cash Flow	-2.66	-2.64	-1.63	-1.16	-1.87	-2.51	-0.92	-1.06	-1.05	-2.24	-0.73	-0.95	-0.95	-1.01	-1.14	-1.10	-0.83	-0.83	-0.49	-0.25
Capital Expenditures	–	–	-0.01	-0.01	–	–	-0.01	0	–	–	–	–	–	–	–	–	–	–	–	–
Investing Cash Flow	-0.04	-0.05	-0.04	-0.04	-0.04	-0.08	-0.06	-0.10	-0.09	-0.06	-0.03	-0.01	-0.06	-0.01	-0.05	-0.04	-0.02	-0.01	-0.05	-0.02
Stock Issued	0	1.04	0.54	0	0	5.17	0	0	0	0	0	0	0	0	0	0	–	–	–	–
Debt Issued	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0.13
Other Financing Activities	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	–	–	–	–
Financing Cash Flow	-0.02	9.68	2.34	-0.28	0.00	17	0.13	1.30	0.19	3.41	1.63	0.52	1.17	0	0	0	0	0.05	2.57	0.32
Free Cash Flow	–	–	-1.64	-1.17	–	–	-0.93	-1.06	–	–	–	–	–	–	–	–	–	–	–	–
Income Taxes Paid	0.00	0	–	–	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	0
Interest Paid	0	0	–	–	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	0

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 21.8%
Operating margin: -11592.1%
Net margin: -10978.5%
Return on equity, FY2025: -104.8%

Financial strength

Current ratio: 16.20
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 1570.5%

Valuation

P/E ratio: –
Price to sales: 67.10
Price to book: 0.33
Dividend yield: –